Health company Zinzino reported a 14 percent increase in revenue to SEK 316.1 million in May, compared to the same month last year. Sales across its markets rose 14 percent to SEK 312.2 million, while Faun Pharma's external sales remained flat at SEK 3.9 million.

For the January-May period, group revenue climbed 23 percent to SEK 1.55 billion. The strongest growth was recorded in South and North America as well as Central Europe, while Eastern Europe saw a decline.